Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics
Florentina Pascale, Julien Namur(Centre National de la Recherche Scientifique), Michel Wassef(Université Paris Cité), Rafael Durán(Centre Hospitalier Universitaire Vaudois), Olivier Pellerin(Hôpital Européen Georges-Pompidou), Alexandre Laurent(Assistance Publique – Hôpitaux de Paris), Jean‐Pierre Pelage, Alban Denys(OLVG), Frédèric Deschamps(Institut Gustave Roussy), S. Ghegediban(Délégation Paris 7), Jean‐Pierre Saint‐Maurice(Hôpital Lariboisière), Noboru Maeda(The University of Osaka), Thierry de Baère(Institut Gustave Roussy)
Cited by 30
Related Papers
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
|PEDIATRICS|2015|1.4k
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
|Cancer Discovery|2017|781
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
|The Lancet. Gastroenterology & hepatology|2020|602
Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas
|The Journal of Pediatrics|1997|499
Rapidly Involuting Congenital Hemangioma: Clinical and Histopathologic Features
|Pediatric and Developmental Pathology|2003|360